March 6, 20261 min
Medically reviewed: 3/6/2026 • Sources verified: 3/6/2026
Retatrutide Safety Profile Phase 3 Discontinuations Bmi Correlation
Explore the retatrutide safety profile from Phase 3 trials, including discontinuation rates, BMI correlation, side effects like dysesthesia, and TRIUMPH-4 results. Key insights on tolerability and future FDA approval.
title: "Retatrutide Safety Profile: Phase 3 Discontinuations and BMI Correlation in TRIUMPH Trials" description
Ready to explore medical weight management?
Consult with US-based telehealth providers to discuss FDA-approved GLP-1 medications and personalized obesity treatment plans.